CFTR and chronic obstructive pulmonary disease: Hence, we propose that restoration of m-/r- CFTR expression may be a promising therapeutic strategy to combat SHS impaired bacterial phagocytosis to control chronic infection and inflammation in COPD-emphysema subjects.